Healthycell

Healthycell

The next-generation nutrient delivery technology replacing tablets, capsules, and powders.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor

€0.0

round
investor

€0.0

Valuation: €0.0

round
*

$1.5m

Early VC
Total Funding000k
Notes (0)
More about Healthycell
Made with AI
Edit

Healthycell operates within the nutritional supplement sector, targeting consumers who are averse to taking pills or seeking more effective nutrient absorption. The company, doing business as Life Science Institute LLC, was founded in 2012, with a significant operational relaunch in 2015 led by CEO Douglas Giampapa. Douglas Giampapa, an entrepreneur with a background in consumer health, took over the company to address what he saw as key challenges in the supplement industry: difficulty in swallowing pills and poor nutrient bioavailability. He is joined by Dr. Vincent Giampapa, a board-certified surgeon and a notable figure in anti-aging medicine, who co-founded Healthycell and serves as its Chief Science Officer. Dr. Giampapa's extensive research in cellular health and new drug delivery systems, for which he holds several patents, provides the scientific foundation for the company's products.

The core of Healthycell's product line is its proprietary, patent-pending MICROGEL™ technology. This delivery system is designed to replace traditional tablets and capsules, which can have low absorption rates due to large, dense particles. MICROGEL™ uses a gel matrix of natural ingredients like citrus pectin and acacia gum to deliver micro-sized, soluble nutrient particles into the digestive tract for enhanced absorption. A clinical study showed that the MICROGEL™ system resulted in up to 165% greater absorption compared to conventional tablets. The company's business model is primarily direct-to-consumer (D2C) through its e-commerce website and Amazon, supplemented by B2B sales through distributors like KeHE. Revenue is generated from the sale of these gel-based supplements, with products priced between approximately $29 and $153. As of December 2023, the company reported an annual revenue of $7.61 million.

Healthycell offers a range of products targeting various health needs, such as immune support, sleep, focus, and healthy aging. Popular products include Bioactive Multi, REM Sleep, and Vegan Essentials. The supplements are sold in single-serving gel packs that can be consumed directly, mixed into drinks, or blended into smoothies. The company emphasizes quality and safety, manufacturing its products in FDA-inspected, GMP-compliant facilities and conducting independent testing to verify contents and purity. Having secured funding through various rounds, including a Series A and equity crowdfunding, Healthycell plans to accelerate customer acquisition, expand into brick-and-mortar retail, and conduct further clinical studies.

Keywords: nutritional supplements, MicroGel, cellular health, bioavailability, pill-free supplements, direct-to-consumer, vitamin gel, nutrient absorption, dietary supplements, anti-aging, Douglas Giampapa, Dr. Vincent Giampapa, sleep aid, multivitamin, vegan supplements, e-commerce nutrition, health and wellness, supplement delivery system, food science, KeHE distributor, Series A, REM Sleep, Bioactive Multi, Focus+Recall, DNA repair

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo